Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection

2021

Jan JT, Cheng TJ, Juang YP, Ma HH, Wu YT, Yang WB, Cheng CW, Chen X, Chou TH, Shie JJ, Cheng WC, Chein RJ, Mao SS, Liang PH*, Ma C*, Hung SC*, and WongCH*

Proceedings of the National Academy of Sciences of the United States of America, 118 (5), e2021579118

A Carbohydrate-Binding Protein from the Edible Lablab Beans Effectively Blocks the Infections of Influenza Viruses and SARS-CoV-2

2020

Liu YM, Md. Shahed-Al-Mahmud, Chen X, Chen TH, Liao KS, Lo JM, Wu YM, Ho MC, Wu CY, Wong CH, Jan JT, Ma C*

Cell Reports, 32(6), 108016

Better influenza vaccines: an industry perspective

2020

Chen JR, Liu YM, Tseng YC & Ma C*

Journal of Biomedical Science, 27(1), 33-44.

Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections.

2019

Tseng YC, Wu CY, Liu ML, Chen TH, Chiang WL, Yu YH, Jan JT, Lin KI, Wong CH*, and Ma C*

Proceedings of the National Academy of Sciences of the United States of America116(10): 4200-4205.

Targeting the bacterial transglycosylase: antibiotic development from a structural perspective.

2019

Chen X, Wong CH, Ma C*

ACS Infectious Diseases, 5(9) 1493-1504.

Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans.

2018

Huang KA, Rijal P, Jiang H, Wang B, Schimanski L, Dong T, Liu YM, Chang P, Iqbal M, Wang MC, Chen Z, Song R, Huang CC, Yang JH, Qi J, Lin TY, Li A, Powell TJ, Jan JT, Ma C, Gao GF*, Shi Y*, Townsend AR*

Nature Microbiology, 4(2): 306-315.

Crystal structure of a homogeneous IgG-Fc glycoform with the N-glycan designed to maximize the antibody dependent cellular cytotoxicity.

2017

Chen CL, Hsu JC, Lin CW, Wang CH, Tsai MH, Wu CY, Wong CH*, Ma C*

ACS Chemical Biology, 12(5), 1335-1345.

A common glycan structure on immunoglobulin G for enhancement of effector functions.

2015

Lin CW, Tsai MH, Li ST, Tsai TI, Chu KC, Liu YC, Lai MY, Wu CY, Tseng YC, Shivatare SS, Wang CH, Chao P, Wang SY, Shih HW, Zeng YF, You TH, Liao JY, Tu YC, Lin YS, Chuang HY, Chen CL, Tsai CS, Huang CC, Lin NH, Ma C, Wu CY*, Wong CH*

Proceedings of the National Academy of Sciences of the United States of America, 112(34), 10611-6.

Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines.

2015

Wu HH, Hwang-Verslues WW, Lee WH, Huang CK, Wei PC, Chen CL, Shew JY, Lee EY, Jeng YM, Tien YW, Ma C, Lee WH*

Journal of Experimental Medicine, 212(3), 333-349.

Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.

2014

Chen JR, Yu YH, Tseng YC, Chiang WL, Chiang MF, Ko YA, Chiu YK, Ma HH, Wu CY, Jan JT, Lin KI*, Ma C*, Wong CH*

Proceedings of the National Academy of Sciences of the United States of America, 111(7), 2476-2481.

Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-kB-mediated antiapoptotic pathway.

2013

Huang CK, Yang CY, Jeng YM, Chen CL, Wu HH, Chang YC, Ma C, Kuo WH, Chang KJ, Shew JY and Lee WH*

Oncogene, 33(23), 2968-77.

Crystal structure of Staphylococcus aureus transglycosylase in complex with a lipid II analog and elucidation of peptidoglycan synthesis mechanism.

2012

Huang CY, Shih HW, Lin LY, Tien YW, Cheng TJR, Cheng WC, Wong CH*, and Ma C*

Proceedings of the National Academy of Sciences of the United States of America, 109(17), 6496-6501.

Vaccine design of hemagglutinin glycoprotein against influenza.

2011

Chen JR, Ma C*, Wong CH*

Trends in Biotechnology, 29, 426-434.